These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 36123895)

  • 21. Comprehensive insights on pivotal prognostic signature involved in clear cell renal cell carcinoma microenvironment using the ESTIMATE algorithm.
    Luo J; Xie Y; Zheng Y; Wang C; Qi F; Hu J; Xu Y
    Cancer Med; 2020 Jun; 9(12):4310-4323. PubMed ID: 32311223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical significance and oncogenic function of NR1H4 in clear cell renal cell carcinoma.
    Huang S; Hou Y; Hu M; Hu J; Liu X
    BMC Cancer; 2022 Sep; 22(1):995. PubMed ID: 36123627
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Cheng X; Sun D; Li H; Zhang J; Luo Q; Jin X; Chen Y; Yuan Q; Wang B
    Transl Androl Urol; 2023 Apr; 12(4):642-658. PubMed ID: 37181237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
    Wu Y; Li X
    Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of genes of prognostic value in the ccRCC microenvironment from TCGA database.
    Wan B; Liu B; Huang Y; Lv C
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1159. PubMed ID: 32012488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients.
    Jiang W; Zeng H; Liu Z; Jin K; Hu B; Chang Y; Liu L; Zhu Y; Xu L; Wang Z; Guo J; Xu J
    Urol Oncol; 2022 Apr; 40(4):166.e15-166.e25. PubMed ID: 34998671
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leukotriene B4 receptor 2 correlates with prognosis and immune infiltration in clear cell renal cell carcinoma.
    Yuan X; He Y; Luo C; Wang W
    Invest New Drugs; 2022 Apr; 40(2):232-244. PubMed ID: 34633577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of IL20RB as a Novel Prognostic and Therapeutic Biomarker in Clear Cell Renal Cell Carcinoma.
    Guo H; Jiang S; Sun H; Shi B; Li Y; Zhou N; Zhang D; Guo H
    Dis Markers; 2022; 2022():9443407. PubMed ID: 35299868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CHEK2 is a potential prognostic biomarker associated with immune infiltration in clear cell renal cell carcinoma.
    Wu Q; Fang C; Wang X; Huang S; Weng G
    Sci Rep; 2023 Dec; 13(1):21928. PubMed ID: 38081888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated bioinformatics analysis to identify the key gene associated with metastatic clear cell renal cell carcinoma.
    Miao S; Song J; Liu Q; Lai J; Wang H; Ran L
    Med Oncol; 2022 Jun; 39(9):128. PubMed ID: 35716215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAM metallopeptidase domain 12 overexpression correlates with prognosis and immune cell infiltration in clear cell renal cell carcinoma.
    Gao J; Yang D; Xu H; Yang K; Ma J; Xia J; Pan X
    Bioengineered; 2022 Feb; 13(2):2412-2429. PubMed ID: 35094638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased expression of tribbles homolog 3 predicts poor prognosis and correlates with tumor immunity in clear cell renal cell carcinoma: a bioinformatics study.
    Wu XQ; Tian X; Xu FJ; Wang Y; Xu WH; Su JQ; Qu YY; Zhao JY; Zhang HL; Ye DW
    Bioengineered; 2022 May; 13(5):14000-14012. PubMed ID: 35726370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
    Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
    BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GBP2 serves as a novel prognostic biomarker and potential immune microenvironment indicator in renal cell carcinoma.
    Tian Y; Wang H; Guan W; Tu X; Zhang X; Sun Y; Qian C; Song X; Peng B; Cui X
    Mol Carcinog; 2022 Dec; 61(12):1082-1098. PubMed ID: 36222186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALDOB represents a potential prognostic biomarker for patients with clear cell renal cell carcinoma.
    Shao Y; Wu B; Yang Z; Liu Z; Ma Y; Huang H; Liu Y; Wang Z; Hu W; Wang Y; Niu Y
    Transl Androl Urol; 2023 Apr; 12(4):549-571. PubMed ID: 37181232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Early Diagnostic and Prognostic Value of BIRC5 in Clear-Cell Renal Cell Carcinoma Based on the Cancer Genome Atlas Data.
    Wang J; Chen M; Dang C; Zhang H; Wang X; Yin J; Jia R; Zhang Y
    Urol Int; 2022; 106(4):344-351. PubMed ID: 34265766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC.
    Hu C; Liu Q; Hu C; Wang Y; Wang P; Zhou X
    Comput Math Methods Med; 2022; 2022():6302234. PubMed ID: 36176741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.